Real-world clinical utility of a multi-protein, blood-based biomarker assay for disease activity assessments in multiple sclerosis.

Summary: Doctors have a new tool to help them treat Multiple Sclerosis (MS). It is a simple blood test that measures 18 different proteins to see how active the disease is in a patient's body. In a recent study looking at over 350 patient charts, doctors found this test to be very helpful. In fact, seeing the test results changed how they treated the patient almost 20% of the time! The test was even more useful when doctors were able to look at multiple results over a period of time. This means the new blood test can help doctors make better, more confident choices for their MS patients.